Company page

Cardiff Oncology, Inc.

Cardiff Oncology, Inc. is a public company traded under the ticker CRDF in the American market, with a market capitalization of approximately $82.7 million. The company focuses on developing innovative treatments for cancer, aiming to improve patient outcomes. Cardiff Oncology is dedicated to advancing its research and development efforts in the oncology sector.